NCT00003766View on ClinicalTrials.gov

O6-benzylguanine Followed by Surgery in Treating Patients With Solid Tumors That Can Be Removed During Surgery

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

October 31, 1999

Primary Completion Date

November 30, 2001

Study Completion Date

November 30, 2001

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

O6-benzylguanine

Trial Locations (1)

60637-1470

University of Chicago Cancer Research Center, Chicago

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Chicago

OTHER

NCT00003766 - O6-benzylguanine Followed by Surgery in Treating Patients With Solid Tumors That Can Be Removed During Surgery | Biotech Hunter | Biotech Hunter